_kid-rock-shotgun-blast-emsp-rare-preview-1.jpg "Kid Rock- Shotgun Blast EMSP RARE from emsp Video Screenshot Preview 1")
Gallery_kid-rock-shotgun-blast-emsp-rare-preview-3.jpg "Kid Rock- Shotgun Blast EMSP RARE from emsp Video Screenshot Preview 3")
Gallery_kid-rock-shotgun-blast-emsp-rare-preview-hqdefault.jpg "Kid Rock- Shotgun Blast EMSP RARE from emsp Video Screenshot Preview hqdefault")
GalleryPlay Video:
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
Jump To Video Parts
⏲ Duration: 2 minutes 32 seconds
👁 View: 19.8K times
Play Audio:👁 View: 19.8K times
Description:
murcielago06gt
murcielago06gt
Share with your friends:
Whatsapp | Viber | Telegram | Line | SMS
Email | Twitter | Reddit | Tumblr | Pinterest
_emsp-boucle-attente-0911.webp "EMSP - Boucle-attente_0911 from emsp")
_emsp-boucle-attente-eals-2022-mp4.webp "EMSP-boucle-attente-EALS-2022.mp4 from emsp")
_under-pressure-poland.webp "I was hired by the European Multiple Sclerosis Platform -EMSP- to coordinate a group of photographers to achieve a broad panorama of what is life like if you have MS in Europe. According to the Eurobarometer, there are substantial differences in terms of access to diagnosis, treatment, drugs, and general empowerment. Walter Astrada, Lurdes R. Basolí, Max Braun, Fernando Moleres and myself, treveled to 12 countries, and shot about 40 people in their context. We did dozens of interviews among peo")
_1-emsp-ectrims-2021-merck-lne-boucle-attente-mp4.webp "1-EMSP-ECTRIMS-2021-MERCK-LNE-BOUCLE ATTENTE.mp4 from emsp")
_emsp-call-to-action-final.webp "EMSP CALL TO ACTION Final from emsp")
_under-pressure-uk-92.webp "There is wide variation across the UK both in access to and quality of MS services. A government report in 2012 identified major problems, including differences in access to services, long wait for diagnosis, poor information and a lack of care coordination.nnIn the MS Barometer, the UK is ranked third-last out of 33 European states when it comes to countries providing disease-modifying treatment, with only 12% of people with MS on such medication.nnA good fact is that the law protects people re")
_emsp-boucle-attente-1-mp4.webp "EMSP-boucle-attente_1.mp4 from emsp")
_n2b-patch-124-ectrims-2019-patients-interviews-124-question-1.webp "N2B-Patch at ECTRIMS 2019 - Patients interviews")
_emsp-boucle-attente-0911.jpg)
_emsp-boucle-attente-eals-2022-mp4.jpg)
_under-pressure-poland.jpg)
_1-emsp-ectrims-2021-merck-lne-boucle-attente-mp4.jpg)
_emsp-call-to-action-final.jpg)
_under-pressure-uk-92.jpg)
_emsp-boucle-attente-1-mp4.jpg)
_n2b-patch-124-ectrims-2019-patients-interviews-124-question-1.jpg)
![[+]](/images/menu.gif){kind=small}